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1. Introduction 
To diagnose a causing agent of viral infections in clinical practice we can use a number of 
laboratory diagnostic methods and procedures. With different pathogens we use different 
methods. What is important is a quality of collected biological samples, time of delivery of 
samples to the laboratory (one hour is the best), appropriate transport in cooling box and 
proper medium for virological examination. Body sites and collection methods vary 
according to the type of infection and viral etiology. We have to take into consideration a 
stage of infection, incubation period, beginning of clinical appearance and dynamic of 
immune response. Storage temperature of samples depends on type of biological material 
and used medium and of course time you need to store the sample. Each type of biological 
sample, such as nasopharyngeal swab tampons, cerebrospinal fluid, content of skin blisters, 
skin biopsies, scabs, urine samples, stool samples and blood fractions such as leukocytes, 
plasma or sera, requires specific way of storage and transport. We introduce a review of the 
most commonly used diagnostic techniques in viral infections: 
1. Growth and isolation of the virus in a cell culture from a specimen taken from the 
patient. Most commonly used are fertilized hen’s egg or laboratory animals. 
2. Detection of virus-specific antibodies in the blood, IgG, IgM, IgA etc. by serological 
testing like ELISA, hemagglutination, complement fixation, blotting, EIA and 
fluorescent antibodies. Levels of immunoglobulins can show us the kinetic of infection. 
3. Viral antigen detection by ELISA in tissues and fluids, or by direct or indirect 
immunofluorescence, or immunoperoxidase. 
4. Detection of virus encoded DNA and RNA (after Rt-RNA procedure) done by 
polymerase chain reaction (PCR) 
5. Histological examination of biopsies taken from infected tissues, or lesion typical for 
viral infection. Looking for viral inclusion bodies, collections of replicating virus 
particles either in the nucleus or cytoplasm. 
6. Visualization of viruses by electron microscopy or immune electron microscopy. 
2. Isolation of virus from tissue cultures 
Viral disease diagnosis has relied on the isolation of viral pathogens in cell cultures. This 
method is often slow and requires considerable technical expertise and equipment. Cell 
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cultures are more convenient and less expensive than eggs and lab animals. Cell cultures are 
suitable to be examined microscopically for evidence of viral proliferation, and, they have 
provided a desirable environment for the detection and identification of many human viral 
pathogens. Viruses reach high titres when grown within susceptible cells, and culture tubes 
are convenient to manipulate. Cell cultures in cell monolayer can be prepared in a variety of 
containers, the 16- by 125-mm glass or plastic round-bottom screw-cap tube is standard.  
Clinical samples collected with a polyester swab from body sites such as skin and the genital 
tract, are usually contaminated with microbial flora, have to be placed in viral transport 
medium, which contain antibiotics, a buffered salt solution, a proteinaceous substance (such 
as albumin, gelatin, or serum), and a pH indicator. Stool samples or other highly 
contaminated samples have to be suspended and filtered through 0,45 μm membrane filters, 
before use. Respiratory tract samples include sputum, bronchial alveolar lavage specimens, 
nasopharyngeal washes, aspirates and swabs and oropharyngeal swabs have to be placed in 
viral transport medium. Specimens which are expected to be free of microbial contamination 
are collected in sterile containers and are not placed in transport medium. Preservation of 
the viral titre and viral infectivity until cell cultures can be inoculated is essential. Keeping 
the samples at 2 to 8°C or on wet ice until cell culture inoculation helps preserve viral 
infectivity and increases the virus recovery rate (Leland, 2007).  
The transport medium tube is vortexed, the swab is discarded, the liquid medium is 
centrifuged, and the supernatant fluid is used to inoculate the cell cultures. Cells are 
cultivated in defined culture media with addition of antibiotics in sterile conditions and all 
handling must be done in laminar flow cabinate (boxes with laminar flow of sterile air). 
Usually after 24 – 48 hours of incubation at 37°C cell exhibit first cytopathic changes. These 
changes are best seen under the inverted microscope. 
Various cell cultures are suitable for cultivation and identification of different viruses. 
Hundreds of cell lineages are available in international cell culture catalogues, most known is 
ATCC (American Type Culture Collection). Examples of well-known cell types are primary 
rhesus monkey kidney (RhMK) cells, primary rabbit kidney cells, human lung fibroblasts 
(MRC-5), human foreskin fibroblasts, human epidermoid carcinoma cells (HEp-2), human 
lung carcinoma cells (A549), and others (Leland, 2007). 
Degenerative changes in monolayer cells provide evidence of viral presence. Viruses are 
quantified in suspension of infected cells, and are classified by number of viral plaques. The 
plaque is identified as a focus of cytopathic changes (swelling, shrinking, and rounding of 
cells to clustering, syncytium formation, and, in some cases, complete destruction of the 
monolayer), around the one infected cell. 
3. Animal tissue cultures 
In addition to use of cell cultures in virology, it’s possible to use tissue cultures for virus 
isolation. Fertile hen’s eggs and laboratory animals like newborn mice are very useful for the 
isolation of certain viruses. Brain cells of newborn mouse are convenient for replication of 
Coxsackie virus, for which cell cultures are not suitable. Methods for identification of 
replicating viruses in living organisms are same like in cell cultures, hemagglutination or 
immunofluorescence using print technique. Immunofluorescence can be used on tissue 
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sections, cultured cell lines, or individual cells and is only limited to fixed (i.e., dead) cells. 
Direct or indirect immunofluorescence can be used for the detection of virus antigen, 
whereas indirect immunofluorescence is virtually always used for the detection of antibody. 
Cells from the culture are immobilized onto glass slide. Specific monoclonal or polyclonal 
sera raised against the viral antigen can be used. Monoclonal sera offer the advantage of 
increased sensitivity and specificity. Samples have to be blocked with specific sera, than 
primary and potentially secondary antibody is added and detected with fluorescent 
microscope. Isolation and identification of unknown virus is very difficult. For ordinary 
isolation our material is sent to laboratory with specific request, for example to isolate 
enterovirus, etc. (Rajčáni ,Čiampor, 2006). 
4. Polymerase Chain Reaction (PCR) 
Detection of virus encoded DNA and RNA (after Rt-RNA procedure) is done with 
polymerase chain reaction. The polymerase chain reaction (PCR) is a scientific technique 
used to amplify a single or a few copies of a piece of DNA across several orders of 
magnitude, generating thousands to millions of copies of a particular DNA sequence.  
Almost all PCR applications use a heat-stable DNA polymerase. This DNA polymerase 
enzymatically assembles a new DNA strand from nucleotides, by using single-stranded 
DNA as a template and DNA primers, which are required for initiation of DNA synthesis.  
PCR method uses thermal cycling, heating and cooling of the PCR sample to a defined series 
of temperature steps, necessary first to denature (physically separate) two strands in a DNA 
double helix at a high temperature 94°C.  
Next step is the hybridization, when at a lower temperature of 50°C two complementary 
primers are attached to the 3´ends of separated strands of the target segment of DNA. PCR 
primers are usually short, chemically synthesized oligonucleotides, with a length not more 
than 30 (usually 18–24) nucleotides. They need to match the beginning and the end of the 
DNA fragment to be amplified and are then used as the template in DNA synthesis by the 
DNA polymerase to selectively amplify the target DNA. 
Third step is a proper synthesis of the new complementary DNA strand. As a starting point 
for DNA synthesis are used PCR primers, because DNA polymerases, can only add new 
nucleotides to an existing strand of DNA.  
Another type of nucleic acid detection is nucleic acid hybridization with virus-specific 
probes detecting specific viruses. Molecular techniques such as dot-blot, Western blot and 
Southern-blot depend on the use of specific DNA/RNA probes for hybridization. The 
specificity of the reaction depends on the conditions used for hybridization. A mixture 
containing the molecule to be detected is applied directly on a membrane as a dot. This is 
then followed by detection by either nucleotide probes. Dot blots can only confirm the 
presence or absence of a viral nucleic acid which can be detected by the DNA probes. 
5. Serology 
When the immune system of a patient encounters a virus, it produces specific antibodies 
which bind to the virus and mark it for destruction. The presence of these antibodies is often 
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used to determine whether a person has been exposed to a given virus in the past. Serology 
is the detection of rising titres of antibodies between an acute and convalescent stage of 
infection, or the detection of IgM in primary infection. There are several serology techniques 
that can be used depending on the antibodies being studied. These include: ELISA, 
agglutination, precipitation, complement-fixation, fluorescent antibodies or Western blot. 
In serologic diagnostic, concrete virus acts as a single antigen, although it represents wide 
antigen mosaic. 
5.1 Agglutination reaction and virus neutralization reaction 
Agglutination reaction and virus neutralization reaction measure effect of antibodies on 
infectivity of the virus, in determinate sera concentration (Rajčáni & Čiampor, 2006). 
5.2 Agglutination test 
When bacteria, antigen-coated particles, or cells in suspension are mixed with antibody 
directed to their surface determinants, reaction leads to agglutination of cells or particles 
carrying the antigen. All antibodies can theoretically agglutinate particulate antigens but 
IgM, due to its high valence, is particularly good. 
Agglutination tests can be used in qualitative or quantitative manner, for presence of 
antibody or to measure the level of antibodies to particulate antigens.  
Serial dilutions of a sample are made to be tested for antibody and then a fixed number of 
red blood cells or bacteria or other antigen is added. The maximum dilution that gives 
visible agglutination is called the titer.  
When the antigen is an erythrocyte the term hemagglutination is used. 
Hemagglutination tests can be subclassified depending on whether they detect antibodies 
against red cell determinants (direct and indirect hemagglutination) or against compounds 
artificially coupled to red cells (passive hemagglutination). 
 Direct hemagglutination – red cells are agglutinated using IgM antibodies recognizing 
epitopes 
- Paul-Bunnell test: diagnosis of infectious mononucleosis, detects circulating cross-
reactive antibodies that combine with antigens of an animal of a different species 
induce the agglutination of sheep or horse erythrocytes 
 Indirect hemagglutination – detects IgG antibodies that react with antigens present in 
the erythrocytes but which by them cannot induce agglutination. A second antibody 
directed to human immunoglobulins is used to induce agglutination. 
- Coombs test: used to test for autoimmune hemolytic anemia. 
 Passive hemagglutination - it is possible to coat erythrocytes with a soluble antigen (e.g. 
viral antigen, a polysaccharide or a hapten) and use the coated red blood cells in an 
agglutination test for antibody to the soluble antigen 
5.3 Complement fixation reaction 
Complement fixation reaction can be used to detect the presence of either specific antibody 
or specific antigen in a patient's serum. The complement system is a system of serum 
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proteins that react with antigen-antibody complexes resulting in the formation of membrane 
pores and therefore destruction of the cell. If the patient's serum contains antibodies against 
the concrete virus, they will bind to the antigen to form antigen-antibody complexes. The 
complement proteins will react with these complexes and be depleted. When commonly 
used sheep red blood cells with their own antibody complexes are added, there will be no 
complement left in the serum. If no antibodies against the concrete virus are present, the 
complement will not be depleted and it will react with the sheep red blood cells antibody 
complexes, lysing the red blood. 
5.4 Enzyme-Linked Immunosorbent Assay (ELISA) 
Enzyme-linked immunosorbent assay (ELISA) serves for detection and quantification of 
specific antibodies in sera. A liquid sample is added onto a solid phase with special binding 
properties and is followed by adding antibodies and other reagents, incubated and washed. 
The result is a color development by the product of an enzymatic reaction. The quantity of 
the analyte is measured by quantitative detection of intensity of transmitted light by 
spectrophotometric method.  
A wide variety of assay principles can be used in ELISA techniques.  
In competitive methods one component of the immune reaction is insolubilized and the 
other one labelled with an enzyme. The anti viral antibodies can then be quantified by their 
ability to prevent the formation of the complex between the insolublized and the labelled 
reagent.  
Sandwich method is the method in which antigen is used in an insolubilized form to bind 
the viral antibody, which is subsequently determined by addition of labelled second 
antibody against the same class of antibody as the analyte antibody.  
5.5 Radioimmunoassay (RIA)  
Radioimmunoassay (RIA) instead of measuring color changes, radioactive substances is 
used to visualize viral antigens. RIA technique is very sensitive and specific, but it requires 
specialized equipment and special precautions and licensing, since radioactive substances 
are used. 
For serologic examination two blood samples (5-10 ml) are needed to confirm existence of 
specific antiviral antibodies. First sample must be taken in the shortest possible time after 
clinical manifestation of viral infection, the latest 5th -6th day. In this sample, levels of 
antibodies are low, but specific IgM antibodies are present. Second sample should be taken 
after appropriate interval depending on the type of infection. In general the most convenient 
is convalescence time, around 21 days after clinical manifestation (Rajčáni & Čiampor, 2006), 
on the other hand according to Sterling (2004) the best time for second blood sample is 10 – 
14 days after first blood sample examination, when first antiviral antibodies start to be 
detectable.  
The best way is to examine both samples at once to compare titres of antibodies. It is 
valuable also individual serological testing, in cases of high antiviral antibody titres.  
Very important is to interpret the results in right way, by specialist. In case of 
immunodeficient or immunosupressed patients results are not valuable (Sterling, 2004).  
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5.6 Fluorescent antibodies or immunofluorescence 
Fluorescent antibodies or immunofluorescence is used primarily on biological samples. 
Technique uses the specificity of antibodies to their antigen to target fluorescent dyes within 
a cell, and therefore allows visualization of the distribution of the target molecule through 
the sample. Immunofluorescence can be used on tissue sections, cultured cell lines, or 
individual cells. In virus diagnosis, we can use specific antibodies to concrete viral capsid 
proteins or to their nucleic acid specific sequences.  
Primary, or direct, immunofluorescence uses a single antibody that is chemically linked to 
a fluorophore. The antibody recognizes the target molecule and binds to it, and the 
fluorophore it carries can be detected via microscopy. 
Secondary, or indirect, immunofluorescence uses two antibodies; the unlabeled primary 
antibody specifically binds the target molecule, and the secondary antibody, which carries 
the fluorophore, recognizes the primary antibody and binds to it. Multiple secondary 
antibodies can bind a single primary antibody. This provides signal amplification by 
increasing the number of fluorophore molecules per antigen. 
6. Diagnosis of hand, foot and mouth disease 
Hand, foot and mouth disease is a human syndrome caused by intestinal viruses of the 
Picornaviridae family. The most common strains causing hand, foot and mouth disease 
(HFMD) are Coxsackie A virus, and Enterovirus 71. 
Biological material from infected individuals must be cultivated in tissue cultures, same as 
used for common virus cultivation. Samples are inoculated mainly on Macacus rhesus or 
cynomolgus kidney tissue, or on human embryonic kidney cells, or WI 38 cells (Chonmaitree 
et al., 1981). Cytopathic effect on cell cultures is monitored and identified using direct 
immunofluorescence, PCR, or RT-PCR (Ooi et al., 2003). 
Using mentioned methods it is possible to identify viral genome directly in samples from 
infected tissues, or in biologic samples from infected persons. Biopsies from infected patient 
can be examined also immunohistochemicaly to prove viral antigens, or with direct and 
indirect immunofluorescence. 
Molecular biology methods do not serve only for verification of the virus in the samples, but 
also for more accurate genotypization of viruses that cause infection (Shimizu et al., 2004). 
Except these diagnostic methods to identify virus causing HFMD, serologic screening can be 
used in clinical practice. From serologic methods, mainly ELISA is used to prove existence 
of virus neutralization antibodies class IgG, IgA, IgM, and anti-gangliozide antibodies GM1, 
GA1, GDa, GDb and GQ1b. Other standard biochemical methods can be used too. 
7. Diagnosis of parvovirus B l9 infection 
Diagnosis of Parvovirus B 19 infection in immunocompetent patients is primarily confirmed 
by detection of anti-viral antibodies. Other assays based on antigen detection have been 
developed, including a receptor mediated hemagglutination assay (RHA), based on 
interaction of Parvovirus B l9 and P antigen on human erythrocytes. Because human 
parvovirus B19 is unable to replicate in culture systems, viral antigens were initially 
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obtained from acutely infected patients. Recently, human Parvovirus B 19 antigens have 
been expressed in different systems. However, bacterial systems for the viral antigens 
undergo denaturation. This phenomenon may be responsible for false negative results due 
to the absence of conformational epitopes. According to several authors these 
conformational epitopes are essential for accurate serologic diagnosis (Manaresi, 2001). In 
l982 Anderson et al., developed a radioimmunoassay (RIA) for detection of specific anti - 
Parvovirus B 19 IgM antibodies. Later, an enzyme - linked immunosorbent assay (ELISA) 
was developed for the detection of specific anti-Parvovirus IgM antibodies (Anderson, 
1986). This assay used virus obtained from viremic patients as an antigen source. 
Specific IgM antibodies are detectable in more than 90% of cases at the end of the first week of 
illness and the titer and positivity rate decreased after 1 month. The sensitivity and specificity 
of ELISA was confirmed by Schwarz et al. (Schwarz 1988) who found that anti - Parvovirus 
B19 IgM could be detected for up to 20 weeks post-viremia and non-specific reactions with 
rheumatoid factor or Rubella were not found. Using immunoblotting, some authors also 
observed that the immune response after acute infection was directed initially against virus 
protein 2 (VP2) and secondly against virus protein (VP1) (Schwarz, 1988). IgM response 
against VP1 linear epitopes is more prevalent and persistent than the one directed against the 
VP2 linear antigen (Palmer, 1996). When the IgM response declines, an IgG immune-response 
against structural proteins VP1 and VP2 becomes prominent and can be detected by IFA, 
Western blot and ELISA. Similarly to the IgM response, specific IgG antibodies are produced 
against both denaturated and undenaturated VP1 and VP2 epitopes. 
Parvovirus B 19 infections are responsible for variety of disorders in humans. The clinical 
presentation is different accordingly to the period of life at which the infection or 
reactivation of the virus occurs. The virus has been extensively studied as causative agent of 
autoimmune diseases (Peterlana, 2006). 
PCR and real time-PCR improve the sensitivity of detection of viral infection and many clinical 
laboratories complement serologic diagnosis with PCR. However, this molecular procedure 
may be necessary only in particular clinical setting because anti-Parvovirus B 19 VP2 IgM has 
been reported to correlate with Parvovirus B 19 DNA level (Beersma, 2005). Therefore the use 
of PCR procedure does not add any further information to a positive serologic test. 
8. Detection of concomitant virus infections 
New opinions in infections, the vaccinations and associated changes of viral antigenic 
qualities, influence clinical symptomatology. These changes in viral factors, including 
virulence and tropism are possible. Co-infection with a second virus has been suggested and 
this theory is supported by concomitant isolation of subgenus B adenovirus with an 
enterovirus from three persons who died during hand, foot and mouth disease (HMFD) 
outbreak in Sarawak (Cardosa, 1999). Among the Singaporean patients with HEV71 
infection, three had second virus isolated concurrently. However, the presence of dual 
viruses did not result in severe disease, although a child with HEV71 (Human enterovirus 
71) and CAV16 (Coxsackie A 16) co-infection died in Singapore in 1997. An epidemic 
outbreak of HFMD occurred in Singapore between September and November 2000. During 
the epidemic, there were four HFMD-related deaths and after the epidemic, another three 
HFMD-related deaths. Enterovirus 71 positive fatal (n = 4) cases and non fatal controls  
(n = 63) were also compared. Of the 131 non fatal cases three had concomitant infections 
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with virus bronchiolitis, right-side pneumonia (respiratory syncytial virus bronchiolitis, 
right-sided pneumonia, Haemophilus influenza type B meningitis ), 2 had aseptic 
meningitis and l had transient drowsiness (Chong, 2003). Since June 2006 till September 2009 
in Europe -in eastern region of Slovakia 295 children have been examined because of 
unknown exanthemas. According to complete history, physical examination, and specific 
viral and serological examinations, viral exanthemas were detected. Parvovirus B 19 
infections were positive in 45 children, Coxsackie B3, B4, B6 serotypes of hand, foot and 
mouth /(HFMD) present in 25 persons. Concomitant dual infection occurred in 20 children. 
Mycoplasma pneumonia and Parvovirus B19 were the most frequent. Authors suggested that 
differences in clinical features of exanthemas, duration of diseases and severe diseases were 
a result of co-infections (Martinaskova, 2010). 
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